Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04226287
Other study ID # A0015
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 16, 2020
Est. completion date August 31, 2020

Study information

Verified date October 2020
Source ResMed
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot study for usability and efficacy, and as such it is designed for 15 participants. The primary objective of this study is to assess the usability of the Monterey Investigational System in the home setting. The primary objective of this study is to assess the usability of the Monterey Investigational System in the home setting over one week of daily use. Usability will be determined using a 11 point Likert Scale where a score of 10 is considered very favorable and a score of 0 is very unfavorable.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date August 31, 2020
Est. primary completion date August 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients who are = 18 years, mentally able to understand and follow the instructions of the study personnel. - A diagnosis of lower limb Lymphedema. - Able to provide written and informed consent. - Patient can read and comprehend English. Exclusion Criteria: - Subject undergoing cancer treatment. - Subject has active lower limb wounds. - Subject is pregnant or trying to become pregnant. - History of pulmonary edema or decompensated congestive heart failure. - Subject has any condition in which increased venous and lymphatic return is undesirable. - Subject has inbuilt electrical stimulator, e.g., cardiac pacemaker

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Monterey Pneumatic Compression Device
The MontereyInvestigational System is a compact pneumatic compression device used for the treatment of either primary or secondary lymphedema. The primary intention in this study is to gather usability design feedback. This will be done by observing how a patient uses the device after a brief demonstration from the clinician. Errors and difficulties will be noted by the ResMed representative observing the trial. The qualitative interview with the patient at the end of the trial will yield additional understanding of the patient experience with the device.

Locations

Country Name City State
United States Progressive Physical Therapy and Rehab Garden Grove California

Sponsors (1)

Lead Sponsor Collaborator
ResMed

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Usability of the Monterey Investigational System in a monitored clinic environment Usability will be determined using a 11 point Likert Scale where a score of 10 is considered very favorable and a score of 0 is very unfavorable. 1 week
Secondary Efficacy of Therapy provided by Monterey Investigational system Efficacy will be determined by comparing lower limb volume measured prior to commencing therapy and at the conclusion. The truncated cone formula is a well-established measure used for assessing limb volume [1]. The limb is divided into segments as per figure 2, measurements taken and volume in each segment is calculated as per the following formula: Voln = L/12(pi)(C1^2+C2^2+C1*C2) 1 week
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05136079 - Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies Phase 3
Completed NCT03917771 - Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer N/A